MedTrace Logo

Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients

NCT01276223 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 722

Last updated 2013-03-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to determine if difluprednate ophthalmic emulsion is effective in reducing the ocular symptoms of dry eye disease, as measured by a global Visual Analog Scale (VAS) discomfort score.

Conditions

Interventions

DRUG

Difluprednate 0.05% ophthalmic emulsion

Topical ocular steroid

OTHER

Difluprednate vehicle

Inactive ingredients used as Run-In and placebo comparator

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01276223 on ClinicalTrials.gov